<code id='EEA049A645'></code><style id='EEA049A645'></style>
    • <acronym id='EEA049A645'></acronym>
      <center id='EEA049A645'><center id='EEA049A645'><tfoot id='EEA049A645'></tfoot></center><abbr id='EEA049A645'><dir id='EEA049A645'><tfoot id='EEA049A645'></tfoot><noframes id='EEA049A645'>

    • <optgroup id='EEA049A645'><strike id='EEA049A645'><sup id='EEA049A645'></sup></strike><code id='EEA049A645'></code></optgroup>
        1. <b id='EEA049A645'><label id='EEA049A645'><select id='EEA049A645'><dt id='EEA049A645'><span id='EEA049A645'></span></dt></select></label></b><u id='EEA049A645'></u>
          <i id='EEA049A645'><strike id='EEA049A645'><tt id='EEA049A645'><pre id='EEA049A645'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:6631
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Study on Amgen’s bispecific immunotherapy produces positive data
          Study on Amgen’s bispecific immunotherapy produces positive data

          TheAmgenboothatESMOinMadrid.AndrewJoseph/STATMADRID—AnoveltypeofimmunotherapyfromAmgengeneratedstron

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo